---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-25-000331"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2025-10-02T23:59:59+00:00"
generated_at: "2026-05-17T04:56:57.792819+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers COO Nader Kabbani transitions to advisory role; Mike Chi promoted to COO

## Summary
- Nader Kabbani steps into advisory role effective Nov 2, 2025, through July 2026.
- Mike Chi, formerly Chief Commercial Officer, appointed COO effective Nov 2, 2025.
- Chi will oversee operations, marketing, product, and commercial functions in consolidated role.
- Chi joined Hims & Hers in April 2021; prior roles include CMO at Zola and VP at INTERMIX.
- Compensation Committee will review potential adjustments to Chi's pay for his expanded responsibilities.

## SEC filing metadata
- accession: 0001773751-25-000331
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2025-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000331/0001773751-25-000331-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000331/hims-20250928.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-25-000331
- JSON: https://secwatch.observer/filing/0001773751-25-000331.json
- Plain text: https://secwatch.observer/filing/0001773751-25-000331.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.